GLP-3 RT 12mg Peptides
Built for exacting studies, this research-grade vial is crafted to deliver dependable performance from the first experiment to the last.
The GLP-3 RT 12mg lyophilized peptide vial is a clean, lab-ready format designed for controlled research workflows. Featuring GLP-3 RT as the active ingredient and a total content of 12mg per vial, this presentation supports precise study design where purity, consistency, and traceability are critical.
- Each vial contains 12mg of GLP-3 RT, supporting reliable reconstitution, consistent assay performance, and reproducible results across validated laboratory models.
This non-edible, lyophilized presentation is intended for professional laboratory environments. The compact, stable powder form integrates smoothly into standard research procedures, enabling researchers to set target concentrations suitable to their protocols. The clean matrix and carefully controlled manufacturing process help reduce variables, allowing focus on experimental design rather than material variability.
Researchers can expect a streamlined handling experience with a lot-coded vial intended for clear documentation and inventory control. Whether used in exploratory screening or structured method development, the 12mg quantity offers practical flexibility for small-batch pilot work and repeatable series. The lyophilized state is selected to help preserve integrity during storage and transport, providing a consistent starting point for study setup when handled according to appropriate laboratory practices.
Quality and trust, from start to finish: At Peptide Scientific Labs, every peptide reflects disciplined standards. Materials are produced in a controlled U.S. facility with stringent quality oversight, including identity and purity verification by advanced analytical methods such as HPLC and mass spectrometry, along with comprehensive lot traceability. Each unit is prepared to support the needs of professional researchers who require dependable, well-characterized inputs. For laboratory research use only. Not for human consumption, clinical, diagnostic, or veterinary use.
- Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
- Shipping is free on orders of $99+ (except Hawaii and Alaska).
- All orders ship in discreet packaging via USPS Ground Advantage mail.
Delivery restrictions vary by state.
Customer Reviews
There are no reviews yet. Be the first to write a review!
Frequently Asked Questions
What is GLP-3 RT?
GLP-3 RT is not a standard pharmacology name, and on research-vendor sites it is often used as shorthand for a retatrutide-style multi-incretin compound. Because that naming is vendor-dependent, the exact identity should be checked on the product page or certificate of analysis. It should therefore be described cautiously as a multi-pathway metabolic research compound.
What is GLP-3 RT typically studied for?
Compounds sold under this label are generally discussed for appetite, glucose regulation, energy expenditure, and multi-receptor incretin signaling. A careful FAQ should avoid presenting the shorthand as if it were a formal drug name and instead tell readers to verify the exact active ingredient before designing research around it.
What are GLP peptides?
GLP peptides — glucagon-like peptides — are a family of peptides derived from the post-translational processing of the proglucagon precursor. The main members are GLP-1 and GLP-2, both of which are produced primarily by intestinal L-cells. GLP-1 is studied in the context of insulin secretion, glucose metabolism, and appetite signaling, while GLP-2 is investigated for its role in intestinal epithelial biology.
A number of synthetic analogs and research compounds exist in this category, including semaglutide-class and tirzepatide-class sequences, as well as dual- and triple-agonist research peptides. All GLP peptide products from Peptide Scientific Labs are lyophilized research materials intended solely for in vitro laboratory investigation.
How do GLP analogs differ from native GLP hormones?
Native GLP-1 has a very short half-life in plasma — on the order of a few minutes — because it is rapidly degraded by the enzyme dipeptidyl peptidase-4 (DPP-4). GLP analogs are engineered peptides that modify the native sequence or attach additional groups such as fatty acid chains, in order to resist DPP-4 degradation, extend half-life, and optimize receptor binding.
This extended stability is what makes GLP analogs useful in research as practical tools for studying the GLP-1 and related receptor systems in controlled experiments. The analogs differ from native GLP hormones primarily in their pharmacokinetic profile and, in some cases, their receptor selectivity across the GLP-1, GIP, and glucagon receptor families.
What is the difference between GLP-1, GLP-2, and GLP-3 in research?
GLP-1 and GLP-2 are both produced from the proglucagon precursor. GLP-1 is studied in connection with the GLP-1 receptor, insulin secretion, and appetite signaling, while GLP-2 is studied primarily in connection with the GLP-2 receptor and intestinal epithelial biology. The two peptides share a common precursor but have different receptor targets and research focuses.
GLP-3 is not a classical endogenous peptide in the same way as GLP-1 and GLP-2. The term is sometimes used as a research label for engineered or triple-agonist peptides that combine activity at GLP-1, GIP, and glucagon receptors in a single molecule. In this sense, GLP-3 in research usually refers to a designed multi-target compound rather than a naturally occurring hormone.
This Product Contains
